Unity Biotechnology, Inc. (UBX) Social Stream
Unity Biotechnology Inc (UBX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering UBX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
UBX's average price target has moved up $1.31 over the prior 44 weeks.
UBX reports an average of 62.69% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
UBX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 31 days, UBX's average broker recommendation rating improved by 0.28.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Unity Biotechnology Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 388.01% of that group.
- In terms of how Unity Biotechnology Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -279.5% of that group.
- In the context of all US stocks, Unity Biotechnology Inc's average analyst price target is higher than 25.12% of them.
- In the context of stocks in the small market cap category, Unity Biotechnology Inc's number of analysts covering the stock is higher than 332.12% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Unity Biotechnology Inc are TYRA, TYME, and TXMD.
What is the outlook for UBX? Use POWR Ratings for clearer insight into price direction.